US Health Spending Set to Exceed $6 Trillion in 2026 on Prescription Drug Surge
The US is expected to spend more than $560 billion on prescription medications in 2026, up 8.2% from…
Eli Lilly’s $1 Trillion Boom: Inside Dave Ricks’ Weight-Loss Bet
June 22, 2026 at 11:30 AM EDT When Dave Ricks became chief executive officer of Eli Lilly &…
CVS Returns Zepbound to Drug Plans After Lilly Slashes Price
More than 10 million US patients will regain easy access to Eli Lilly & Co.’s obesity shot Zepbound…
Trump Touts Drug Cost Savings in TrumpRx Website Launch
President Donald Trump launched a new website to help Americans directly buy select medicines at a discount, seeking…
Obesity, M&A, Biotech Resurgence: A 2026 Guide to Health Stocks
The health-care corner of the US equity market has traditionally been viewed as defensive, thanks to steady growth…
European Obesity Stocks Join Healthcare Rally as AI Trade Ebbs
European weight-loss drug developers have staged something of a comeback this week, as investors rotate into healthcare from…
Trump’s Wegovy and Zepbound Drug Price Deal Is Short on Details
A White House deal with Eli Lilly & Co. and Novo Nordisk to lower the prices of their…
Pfizer Sweetens Its Offer for Metsera in Bidding War Against Novo
Pfizer Inc. agreed to buy Metsera Inc. for up to $10 billion, prevailing over Novo Nordisk A/S in…
How Voyaging to Mars Risks Harming an Astronaut’s Eyes – Bloomberg.com
How Voyaging to Mars Risks Harming an Astronaut’s Eyes Bloomberg.comSpaceflight alters brain fluid more in women, while men face…
Metsera Weight-Loss Drug Shows ‘Excellent’ Tolerability in Study
Metsera Inc.’s next-generation weight-loss drug showed good tolerability with few participants dropping out of a mid-stage trial, adding…
Lilly and Novo Rise on Report of Deal for Medicare Coverage
Shares of Eli Lilly & Co and Novo Nordisk A/S rose on a report that the companies were…
Pfizer Races to Salvage Obesity Drugmaker Deal After Novo’s Bid – Bloomberg.com
Pfizer Races to Salvage Obesity Drugmaker Deal After Novo’s Bid Bloomberg.comNovo Nordisk’s Metsera bid shows how far it’ll go…